Joshua Silverman has bought stock on 2 days since Jun 2021

Joshua N. Silverman is the Interim Chief Executive Officer, President, and Chairman of PharmaCyte Biotech, Inc. (PMCB), positions he has held since October 2022.( Aged 55-56, he earned a B.A. from Lehigh University in 1992 and has a extensive background in finance and public company governance.(

Silverman co-founded and served as Co-Chief Investment Officer at Iroquois Capital Management from 2003 to 2016, and previously as Co-CIO at Vertical Ventures from 2000 to 2003.( He is Co-Founder and Managing Member of Parkfield Funding LLC, and holds multiple board roles including Chairman at Petros Pharmaceuticals, Executive Chairman at TAO Synergies (formerly Synaptogenix), and Director at Femasys.( Recently, as PMCB CEO, he purchased 100,000 shares for approximately $80,000 between January 5-7, 2026, bringing his direct ownership to 416,250 shares.(

Written by Perplexity from public sources.